| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
VolitionRX (AMEX:VNRX) will release its quarterly earnings report on Thursday, 2025-11-13. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate VolitionRX to report an earnings per share (EPS) of $-0.05.
Investors in VolitionRX are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
The company's EPS missed by $0.01 in the last quarter, leading to a 7.94% increase in the share price on the following day.
Here's a look at VolitionRX's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.05 | -0.05 | -0.05 | -0.07 |
| EPS Actual | -0.06 | -0.06 | -0.06 | -0.07 |
| Price Change % | 8.00 | -5.00 | -9.00 | -6.00 |
Shares of VolitionRX were trading at $0.38 as of November 11. Over the last 52-week period, shares are down 46.25%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for VolitionRX visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VNRX
